NEUROCRINE BIOSCIENCES INC Weighted Average Number of Shares Outstanding, Basic and Diluted
NEUROCRINE BIOSCIENCES INC (NBIX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 91.06 million shares for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-04-29.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2019-04-29
- NEUROCRINE BIOSCIENCES INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2019-03-31 was 91.06M shares, a 1.71% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-06-30 was 90.10K shares, a 2.31% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2018-03-31 was 89.53M shares, a 2.57% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2017-09-30 was 88.33M shares, a 1.78% increase year-over-year.
- NEUROCRINE BIOSCIENCES INC weighted average number of shares outstanding, basic and diluted for fiscal 2016 was 86.71M shares, a 2.62% increase from fiscal 2015.
- NEUROCRINE BIOSCIENCES INC weighted average number of shares outstanding, basic and diluted for fiscal 2015 was 84.50M shares, a 13.30% increase from fiscal 2014.
- NEUROCRINE BIOSCIENCES INC weighted average number of shares outstanding, basic and diluted for fiscal 2014 was 74.58M shares, a 11.33% increase from fiscal 2013.
- NEUROCRINE BIOSCIENCES INC weighted average number of shares outstanding, basic and diluted for fiscal 2013 was 66.99M shares.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|---|---|
| 2019-03-31 | 91.06M shares 10-Q · filed 2019-04-29 | |||||
| 2018-06-30 | 90.10K shares 10-Q · filed 2018-07-31 | 89.81K shares 10-Q · filed 2018-07-31 | ||||
| 2018-03-31 | 89.53M shares 10-Q · filed 2019-04-29 | |||||
| 2017-09-30 | 88.33M shares 10-Q · filed 2017-11-01 | 44.21M shares derived: average of 2 quarters · filed 2018-07-31 | 87.89M shares 10-Q · filed 2017-11-01 | 65.64M shares derived: average of 4 quarters · filed 2018-07-31 | ||
| 2017-06-30 | 88.06K shares 10-Q · filed 2018-07-31 | 88.06M shares 10-Q · filed 2017-08-03 | 87.67K shares 10-Q · filed 2018-07-31 | 87.67M shares 10-Q · filed 2017-08-03 | 58.08M shares derived: average of 3 quarters · filed 2018-07-31 | 65.26M shares derived: average of 4 quarters · filed 2018-07-31 |
| 2017-03-31 | 87.28M shares 10-Q · filed 2018-04-30 | 87.08M shares derived: average of 2 quarters · filed 2018-04-30 | 86.98M shares derived: average of 3 quarters · filed 2018-04-30 | 86.91M shares derived: average of 4 quarters · filed 2018-04-30 | ||
| 2016-12-31 | 86.87M shares 10-K · filed 2018-02-13 | 86.83M shares derived: average of 2 quarters · filed 2018-02-13 | 86.78M shares derived: average of 3 quarters · filed 2018-02-13 | 86.71M shares 10-K · filed 2018-02-13 | ||
| 2016-09-30 | 86.78M shares 10-K · filed 2018-02-13 | 86.74M shares derived: average of 2 quarters · filed 2018-02-13 | 86.66M shares 10-Q · filed 2017-11-01 | 86.54M shares derived: average of 4 quarters · filed 2018-02-13 | ||
| 2016-06-30 | 86.69M shares 10-K · filed 2018-02-13 | 86.59M shares 10-Q · filed 2017-08-03 | 86.46M shares derived: average of 3 quarters · filed 2018-02-13 | 86.31M shares derived: average of 4 quarters · filed 2018-02-13 | ||
| 2016-03-31 | 86.50M shares 10-K · filed 2018-02-13 | 86.34M shares derived: average of 2 quarters · filed 2018-02-13 | 86.18M shares derived: average of 3 quarters · filed 2018-02-13 | 86.01M shares derived: average of 4 quarters · filed 2018-02-13 | ||
| 2015-12-31 | 86.18M shares 10-K · filed 2017-02-14 | 86.02M shares derived: average of 2 quarters · filed 2017-02-14 | 85.85M shares derived: average of 3 quarters · filed 2017-02-14 | 84.50M shares 10-K · filed 2017-02-14 | ||
| 2015-09-30 | 85.86M shares 10-K · filed 2017-02-14 | 85.69M shares derived: average of 2 quarters · filed 2017-02-14 | 83.93M shares 10-Q · filed 2016-11-02 | 81.97M shares derived: average of 4 quarters · filed 2017-02-14 | ||
| 2015-06-30 | 85.52M shares 10-K · filed 2017-02-14 | 82.95M shares 10-Q · filed 2016-08-03 | 80.67M shares derived: average of 3 quarters · filed 2017-02-14 | 79.49M shares derived: average of 4 quarters · filed 2017-02-14 | ||
| 2015-03-31 | 80.35M shares 10-K · filed 2017-02-14 | 78.24M shares derived: average of 2 quarters · filed 2017-02-14 | 77.48M shares derived: average of 3 quarters · filed 2017-02-14 | 77.08M shares derived: average of 4 quarters · filed 2017-02-14 | ||
| 2014-12-31 | 76.14M shares 10-K · filed 2016-02-11 | 76.04M shares derived: average of 2 quarters · filed 2016-02-11 | 75.99M shares derived: average of 3 quarters · filed 2016-02-11 | 74.58M shares 10-K · filed 2016-02-11 | ||
| 2014-09-30 | 75.95M shares 10-K · filed 2016-02-11 | 75.91M shares derived: average of 2 quarters · filed 2016-02-11 | 74.05M shares 10-Q · filed 2015-10-29 | 72.36M shares derived: average of 4 quarters · filed 2016-02-11 | ||
| 2014-06-30 | 75.88M shares 10-K · filed 2016-02-11 | 73.08M shares 10-Q · filed 2015-07-29 | 71.16M shares derived: average of 3 quarters · filed 2016-02-11 | 70.17M shares derived: average of 4 quarters · filed 2016-02-11 | ||
| 2014-03-31 | 70.26M shares 10-K · filed 2016-02-11 | 68.80M shares derived: average of 2 quarters · filed 2016-02-11 | 68.27M shares derived: average of 3 quarters · filed 2016-02-11 | 67.90M shares derived: average of 4 quarters · filed 2016-02-11 | ||
| 2013-12-31 | 67.35M shares 10-K · filed 2015-02-09 | 67.27M shares derived: average of 2 quarters · filed 2015-02-09 | 67.11M shares derived: average of 3 quarters · filed 2015-02-09 | 66.99M shares 10-K · filed 2015-02-09 | ||
| 2013-09-30 | 67.20M shares 10-K · filed 2015-02-09 | 67.00M shares derived: average of 2 quarters · filed 2015-02-09 | 66.87M shares 10-Q · filed 2014-11-04 | |||
| 2013-06-30 | 66.80M shares 10-K · filed 2015-02-09 | 66.70M shares 10-Q · filed 2014-08-06 | ||||
| 2013-03-31 | 66.60M shares 10-K · filed 2015-02-09 | |||||
| 2012-09-30 | 66.34M shares 10-Q · filed 2013-10-29 | 66.33M shares derived: average of 2 quarters · filed 2013-10-29 | 65.36M shares 10-Q · filed 2013-10-29 | |||
| 2012-06-30 | 66.31M shares 10-Q · filed 2013-07-26 | 64.86M shares 10-Q · filed 2013-07-26 | ||||
| 2012-03-31 | 63.41M shares 10-Q · filed 2013-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |